Evidence map›Paper›PMID 36686314›Full record

ArticleCanadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC

Community pharmacist perceptions of drug-drug interactions.

Karen Dahri, Louise Araujo, Si Chen, Harkaryn Bagri, Keerti Walia, Louise Lau, Michael Legal

Open access · greenAbstract read
In one paragraph

Article in Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Karen DahriVancouver General Hospital, Vancouver Coastal Health.ORCID https://orcid.org/0000-0001-5653-6056
Louise AraujoFaculty of Pharmaceutical Sciences, University of British Columbia.
Si ChenFaculty of Pharmaceutical Sciences, University of British Columbia.
Harkaryn BagriSurrey Memorial Hospital, Fraser Health Authority, Surrey.
Keerti Waliacommunity pharmacist in several locations in Vancouver, BC.
Louise LauVancouver General Hospital, Vancouver Coastal Health.
Michael LegalFaculty of Pharmaceutical Sciences, University of British Columbia.
University of British Columbia · CAVancouver Coastal Health · CAAmerican Pharmacists Association · USFraser Health · CAProvidence Health Care · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Drug-drug interactions are preventable medication errors that can lead to serious negative outcomes for patients. Community pharmacists are uniquely positioned with their medication knowledge and role in prescription clinical assessment. However, workplace pressures and limitations related to computer systems can lead to drug-drug interactions being missed. There is a lack of information as to how community pharmacists assess drug interactions. Methods: A qualitative study using key informant interviews of community pharmacists was conducted. Pharmacists were questioned on their perceptions and views of drug interactions. Results: Eight community pharmacists participated. Four main themes were identified from the interviews: 1) pharmacist process of identifying drug interactions, 2) tools that help pharmacists assess and respond to drug interactions, 3) challenges in identifying and responding to clinically important drug interactions and 4) measures to avoid missing interactions. Discussion: Community pharmacists experience challenges around their lack of access to patient information, which limits their ability to properly assess drug-drug interactions. In addition, increasing workload pressures have affected their ability to ensure their patients receive optimal pharmaceutical care. There is also a disconnect between the community pharmacy computer systems' alerts and their clinical relevancy to their specific patients. The overall burdens can lead to professional abstinence in the assessment of drug-drug interactions. Conclusion: Community pharmacists are in an ideal position to prevent patients from experiencing drug-drug interactions. However, to further enable them to fulfill this role, increased access to patients' health records, decreased workload and better customization of computer alerts need to occur.

Identifiers

PMID36686314
PMCPMC9849923
OpenAlexW4312060398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.